id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-1997-M-0061-0001,FDA,FDA-1997-M-0061,"Tab C: Vitreon Labeling re: Vitrophage, Inc.; Premarket Approval of VITREON",Notice,Notice of Approval,1998-01-14T05:00:00Z,1998,1,1998-01-14T05:00:00Z,1998-02-03T04:59:59Z,2024-12-02T14:08:29Z,,0,0,09000064805d030e
FDA-1997-M-0061-0003,FDA,FDA-1997-M-0061,"Tab A: Order re: Vitrophage, Inc.; Premarket Approval of VITREON",Notice,Notice of Approval,1998-01-14T05:00:00Z,1998,1,1998-01-14T05:00:00Z,1998-02-03T04:59:59Z,2024-12-02T14:11:06Z,,0,0,09000064805d0312
FDA-1997-M-0061-0004,FDA,FDA-1997-M-0061,"Vitrophage, Inc.; Premarket Approval of VITREON",Notice,Notice of Approval,1998-01-14T05:00:00Z,1998,1,1998-01-14T05:00:00Z,1998-02-03T04:59:59Z,2024-12-02T14:04:55Z,97-34157,0,0,09000064805d0313
FDA-1997-M-0061-0002,FDA,FDA-1997-M-0061,"Tab B: Summary of Safety and Effectiveness Data re: Vitrophage, Inc.; Premarket Approval of VITREON",Notice,Notice of Approval,1998-01-14T05:00:00Z,1998,1,1998-01-14T05:00:00Z,1998-02-03T04:59:59Z,2024-12-02T14:09:39Z,,0,0,09000064805d0310